Related Experiment Video
Updated: May 31, 2025
![[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59739.jpg&w=3840&q=50)
[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
Published on: May 21, 2019
Photoredox-Mediated Immunotherapy Utilizing Rhenium(I) Photocatalysts with Electron Donor-Acceptor-Donor
Dan Li1, Guoqing Wen1, Haobing Wang1
1College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China.
This study introduces novel rhenium(I) complexes for photodynamic therapy in hypoxic tumors. These photosensitizers trigger ferroptosis and immunotherapy, effectively suppressing tumor growth.
Area of Science:
- Inorganic Chemistry
- Photochemistry
- Cancer Therapy
Background:
- Hypoxic tumors limit oxygen-dependent photodynamic therapy efficacy.
- Photoredox catalysis offers a promising strategy to overcome hypoxia-induced limitations.
- Efficient photosensitizers are crucial for advanced cancer treatments.
Purpose of the Study:
- To design and synthesize novel rhenium(I) tricarbonyl complexes for photodynamic therapy.
- To investigate the photophysical properties and photosensitizing capabilities of these complexes.
- To evaluate their therapeutic efficacy against hypoxic tumors via photoredox catalysis.
Main Methods:
- Rational design of rhenium(I) tricarbonyl complexes (Re-TPO and Re-TP) with D-A-D configuration.
- Characterization of aggregation-induced emission and spin-orbit coupling properties.
- Assessment of reactive oxygen species generation, metabolic intervention (NADH/NAD+, pyruvate/lactate), and tumor suppression in vivo.
Main Results:
- Re-TP demonstrated enhanced photosensitizing capability due to aggregation-induced emission and increased spin-orbit coupling.
- Excited Re-TP induced type I and II reactive oxygen species, oxidized NADH, and reduced pyruvic acid.
- Metabolic disruption triggered PD-L1 immune responses, ferroptosis, and immunogenic cell death, suppressing B16 tumors.
Conclusions:
- The developed rhenium(I) complexes, particularly Re-TP, show significant potential as photosensitizers for photoredox-mediated photoimmunotherapy.
- This approach effectively combats hypoxic tumors by combining ferroptosis and immunotherapy.
- The study presents a valuable model for designing metal-based photosensitizers for challenging tumor microenvironments.
Related Concept Videos
Photochemical Electrocyclic Reactions: Stereochemistry
Selection Rules: Photochemical Activation
The Photochemical Reaction Center
Cycloaddition Reactions: MO Requirements for Photochemical Activation
Thermal and Photochemical Electrocyclic Reactions: Overview
The Z-Scheme of Electron Transport in Photosynthesis
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...

